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Background: Neonatal hyperbilirubinemia is a recognized health risk for newborns. 
It can cause kernicterus and hearing impairment. Certain groups of infants who do not 
have significant jaundice during the first few days of life develop hyperbilirubinemia 
later. Because early discharge is a worldwide trend, prompt identification of this 
group of infants is of paramount importance in preventing complications.
Methods: The data used were derived from a medical center. A total of 523 term 
or near-term infants were enrolled in this study. All infants were scheduled for 
follow-up visits. In this study, late-onset neonatal hyperbilirubinemia was defined as a 
total bilirubin level greater than 15 mg/dL, or receiving phototherapy at 5−7 days. 
Newborns that had clinically significant jaundice within 96 hours of life were 
excluded from analysis. Univariate and multivariate logistic regressions were 
applied for statistical analysis.
Results: One hundred and eighty infants were included for data analysis. Thirty-nine 
(21.7%) had late onset hyperbilirubinemia. Exclusive breast-feeding and less body 
weight loss during the 1st day of life were both significant risk factors for late onset 
hyperbilirubinemia. However, early discharge was not associated with late-onset 
hyperbilirubinemia.
Conclusion: Thirty-nine (21.7%) infants develop late hyperbilirubinemia at the age 
of one week. Exclusive breast-feeding and less body weight loss were significant 
risk factors. Follow-up visits are recommended for all infants, especially for those 
who have these risk factors.
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1. Introduction
Neonatal hyperbilirubinemia is a health risk for 
newborns.1 Approximately 60% of newborn infants 
(2.4 million) develop clinical jaundice every year 
in the United States.2 It is one of most common 
reasons for neonatal readmission3−6 and has been 
the focus of attention in recent years for two reasons. 
First, cases of kernicterus have been occasionally 
reported in the United States7,8 and Europe,9 although 
the American Academy of Pediatrics (AAP) provided 
practical guidelines for neonatal hyperbilirubine-
mia in 1994.2 Second, other minor neurological abnor-
malities have been reported among infants with 
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hyperbilirubinemia.10,11 The sequelae of hyperbi l-
irubinemia include kernicterus, permanent brain 
damage,8,12 and hearing impairment.13 These compli-
cations can be prevented by phototherapy (blue 
light) or blood exchange transfusion14 if hyperbil-
irubinemia is detected early.
Currently, early discharge—even within 24 hours 
of birth—is a worldwide trend in obstetric care. 
However, there are certain groups of infants who 
do not have significant jaundice in the first several 
days of life but develop it later. Therefore, the AAP 
recommends that all infants discharged before the 
age of 48 hours should be followed up within 2−3 
days after discharge.2 The follow-up rate has been 
reported to be low even in the United States.15
Early identification of these groups of infants 
is of paramount importance in preventing compli-
cation. This study was designed to analyze the risk 
factors for infants who develop late-onset neonatal 
hyperbilirubinemia.
2. Materials and Methods
The study subjects were neonates in the well-baby 
nursery of a medical center located in central Taiwan. 
According to the regulations of the National Health 
Insurance (NHI) of Taiwan, newborn infants are ob-
served in the hospital for 3 days if they are born by 
vaginal delivery, and for 5 days if by cesarean section. 
Breast-feeding is encouraged in this medical 
center. Mothers receive information and care from 
the staff during the whole peripartum stay. Infant 
formula was not given unless requested by parents 
or prescribed by pediatricians under certain medical 
circumstances.
This study included 639 infants who were born 
at the medical center between October 2003 and 
April 2004. Of these, 531 were term or near-term 
and were cared for at the well-baby nursery. Term or 
near-term infants with gestational age > 35 weeks 
and birth weight > 2000 g were enrolled. Sick in-
fants who were transferred to the intensive care 
unit or sick baby nursery were excluded. Newborns 
with significant jaundice, defined as having a bil-
irubin level higher than the 95 percentile on the 
nomogram, plotted by continuous monitoring of the 
639 infants in our nursery, or receiving photother-
apy within 96 hours after birth, were not included. 
Gender, G6PD deficiency, pregnancy history, deliv-
ery pattern, feeding pattern, birth weight, blood 
type, maternal age, and body weight were col-
lected for risk factor analysis.
All parents received a card on which the follow -
up date and the reason for follow-up were writ-
ten. During follow-up visits, all infants received 
complete physical examinations, their medical 
history was briefly recorded, and transcutaneous 
bilirubin (TcB) measurements were taken using a 
BiliCheck device (American Laubscher Corporation, 
Farmingdale, NY, USA). If the bilirubin level was 
over 15 mg/dL, total serum bilirubin was rechecked 
for confirmation. Late-onset neonatal hyperbil-
irubinemia was defined as having a TcB level 
greater than 15 mg/dL or receiving phototherapy at 
5−7 days.
Both univariate and multivariate logistic regres-
sion models were applied. The risks were presen-
ted as odds ratios with 95% confidence intervals. 
The stepwise method was adapted in variable se-
lection for multivariable logistic regression. The 
entry criterion was set at 0.2 and the stay criterion 
at 0.1. The body weight loss percentage between 
groups was compared by non-parametric (Mann-
Whitney U) tests. Statistical significance was 
defined as p < 0.05.
3. Results
Eight infants were excluded: four had a birth 
weight ≤ 2000 g; the other four, who were sus-
pected of having hemolytic diseases, received 
phototherapy within 48 hours after birth. A total of 
523 infants were enrolled in this study. Among 
them, 231 infants had available bilirubin data at 
one week either from the follow-up clinic or well-
baby nursery records. The demographic data of 
the follow-up and the non-follow-up groups were 
compared and are summarized in Table 1. Infants 
having gestational age less than 37 weeks, born by 
cesarean section, or not exclusively breastfed 
were more likely to be followed-up. Among these 
231 infants, 51 with significant jaundice within 96 
hours post-birth were excluded. Of the remaining 
180 infants, 39 (21.7%) were diagnosed as having 
late-onset hyperbilirubinemia. The study cohort is 
summarized in Figure 1. The results of univariate 
and multivariate logistic regression for risk factor 
analysis are shown in Table 2. In univariate analy-
sis, exclusive breast-feeding at the end of the first 
week, vaginal delivery, and body weight loss dur-
ing the first day of life were significant variables. 
We further analyzed these three risk factors in a 
multivariate logistic regression model by stepwise 
selection of variance. Only exclusive breast-feed-
ing and less body weight loss during the 1st day of 
life were considered significant. Early discharge 
within 72 hours was not a risk factor 
either in the univariate or multivariate models.
Because infants with more body weight loss 
during the first day had less late-onset neonatal 
hyperbilirubinemia, we further analyzed the correla-
tion by a scatter plot in regression analysis, and the 
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p value revealed statistical significance. However, 
when comparing birth weight and weight at 7 days, 
we did not find any significant difference between 
the jaundiced and non-jaundice groups.
We further analyzed the effect of exclusive 
breast-feeding by plotting the median TcB values 
for infants who were exclusively breastfed versus 
those who were not (Figure 2). Analysis revealed 
that breastfeeding infants did not have higher 
median TcB values in the first 4 days of life. 
4. Discussion
In this study, we found that some infants who had 
no significant jaundice during the 3-day well-baby 
nursery stay developed jaundice later. We defined 
this phenomenon as late-onset neonatal hyperbil-
irubinemia and tried to analyze the risk factors 
involved.
Phototherapy is indicated where bilirubin levels 
exceed 15 mg/dL, according to the Bureau of 
National Health Insurance, Taiwan. Choosing 
15 mg/dL as the cut-off point may lead to lower 
specificity but may reduce false negative cases. If 
the cutoff point was set at 18 mg/dL, there would 
only be seven cases of late-onset hyperbilirubine-
mia in our study. Using multivariate logistic regres-
sion, we found that exclusive breastfeeding until 
7 days is a significant risk factor for late-onset 
neonatal hyperbilirubinemia. It is compatible with 
previous epidemiological findings that show breast-
fed infants have higher bilirubin levels and longer 
periods of jaundice.16−19
Some infants who were discharged within 72 
hours after birth developed hyperbilirubinemia at 
the 4th day after birth and were considered as 
cases of late-onset hyperbilirubinemia. This result 
may lead to outcome measure misclassification. 
We do not think this is a major limitation because 
the aim of this study was to determine risk factors 
for infants who should be followed-up after dis-
charge. Furthermore, this kind of misclassification 
is non-differential and can lead the results toward 
the null value. It may also move the risk factors 
further from significance in statistical analysis.
In the regression model, we found that infants 
with greater body weight loss during the 1st day 
had less late-onset neonatal hyperbilirubinemia. 
This is in contrast to the calorie-deprivation theory 
suggested in previous studies.20,21 Our study does 
not enable the elucidation of the cause of this 
phenomenon. The body weight discrepancy was 
not significant at follow-up.
Whether early discharge is a risk factor for late-
onset neonatal hyperbilirubinemia and neonatal 
Table 1 Comparison of demographic data of infants who were followed-up at 1 week and those who were not
 Followed up (n = 231) Not followed up (n = 292) p
Male sex 53.9% 51.6% 0.619
G6PD deficiency 0% 2% 0.102
First pregnancy 39.3% 32.8% 0.142
Cesarean section 47.8% 26.0% < 0.001*
Exclusive breast-feeding 32.2% 42.5% 0.022*
Birth weight > 3500 g 18.3% 17.2% 0.747
ABO incompatibility 15.5% 13.8% 0.613
Maternal age > 35 yr 24.4% 21.9% 0.504
Preterm (GA 35−37 wk) 17.3% 7.6% 0.001*
Birth body weight (g) 3106 ± 34  3157 ± 21  0.171
*Statistically significant by Pearson’s χ2 test. G6PD = glucose-6-phosphate dehydrogenase; GA = gestational age.
Figure 1 Summary of the study cohort. SBR = sick baby 
nursery; NICU = neonatal intensive care unit.
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readmission is still a point of controversy in the 
United States.3,4,6 As we know, a substantial 
propor tion of neonatal readmission can be attrib-
uted to hyperbilirubinemia.3−6 In this study, regu-
lar discharge within 72 hours after birth was not a 
significant risk factor for late-onset neonatal hyper-
bilirubinemia; this means observation for 2−3 or 
4−5 days in the well-baby nursery made little dif-
ference in preventing late-onset hyperbilirubinemia. 
From the perspective of insurance policymaking, 
follow-up at clinics may be more important than 
keeping babies in the nursery for 1 or 2 more days.
Comparison of demographic data showed that 
infants of gestational age between 35−37 weeks, 
birth by cesarean section, or exclusively breast-
fed babies were more likely to be followed-up. 
This is because both physicians and parents were 
more concerned when they observed that the in-
fants had jaundice. As a risk factor, it may be over-
presented because almost all of these babies were 
Figure 2 Median transcutaneous bilirubin (TcB) values for infants who were exclusively breast-fed vs. those who 
were not—there was no significant difference between the two groups.
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Table 2 Risk factor analysis for late-onset neonatal hyperbilirubinemia
Risk factor
 Late-onset hyperbilirubinemia* Odds ratio (95% CI)
 Yes (n = 39) No (n = 141) Univariate p Multivariate p
Male gender 61.5% (24/39) 51.8% (73/141) 1.49 (0.72−3.07) 0.28 − 
G6PD deficiency 0% (0/39) 0% (0/141)   − 
First pregnancy 35.9% (14/39) 40.3% (56/139) 0.83 (0.40−1.73) 0.62 − 
CS 33.3% (13/39) 51.8% (74/141) 0.47 (0.22−0.98) 0.04 0.67 (0.29−1.54) 0.35
Exclusive BF 41% (16/39) 29.8% (42/141) 1.64 (0.79−3.41) 0.18 − 
Giant baby 28.2% (11/39) 15.6% (22/141) 2.13 (0.92−4.89) 0.07 1.64 (0.63−4.27) 0.31
ABO 15.4% (6/39) 15.6% (21/135) 0.99 (0.37−2.65) 0.98 − 
 incompatibility
Maternal 20.5% (8/39) 25.5% (36/141) 0.75 (0.32−1.79) 0.52 − 
 age > 35 yr
Preterm 23.7% (9/38) 15.6% (22/141) 1.68 (0.7−4.03) 0.24 − 
Early discharge 46.2% (18/39) 34.8% (49/141) 1.61 (0.78−3.30) 0.19 − 
Exclusive 68.6% (24/35) 45.5% (61/134) 2.61 (1.18−5.76) 0.02 2.58 (1.10−6.06) 0.03
 BF till 7 d
BW loss (%)  3.02 ± 0.13% 3.92 ± 0.31% 0.69 (0.53−0.89) 0.01 0.70 (0.52−0.93) 0.02
 in first 24 hr
BW change at −3.26 ± 6.14% −2.94 ± −6.02%  0.62
 age of 7 d
*Data from follow-up clinic for 89 infants and from daily nursery record for the other 91 infants. BF = breast-feeding; BW = body 
weight; CS = cesarean section; CI = confidence interval; G6PD = Glucose-6-phosphate dehydrogenase.
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followed up. Because most infants delivered by ce-
sarean section were discharged at day 6 or day 7 
after birth—according to National Health Insurance 
policy—there was a significantly higher follow-up 
rate for infants born by cesarean section. To con-
trol for possible confounding factors, we used mul-
tiple logistic regression analysis. Because exclusive 
breastfeeding was highly correlated with delivery 
type (48.1% exclusive breastfeeding rate for vagi-
nal delivery vs. 20.6% for cesarean section), only 
the delivery type was chosen for multiple logistic 
regression to avoid co-linearity. We controlled for 
cesarean section and the two significant risk 
factors—exclusive breast-feeding until 7 days post-
partum and less body weight loss during the first 
day. Both were evenly distributed between follow-up 
and non-follow-up groups; we therefore do not be-
lieve there is major selection bias in our study.
After comparing babies who were followed-up 
with those who were not, we found there were 
only differences in cesarean section rate, exclu-
sive breast-feeding, and preterm infants. All three 
variables were controlled using multivariate 
regression models. We believe that bias caused by 
dropouts would be minor. 
In summary, there are certain groups of infants 
who appeared normal in the well-baby nursery 
that developed jaundice at 1 week. Exclusive 
breastfeeding and less body weight loss during the 
first day of life are significant risk factors for 
developing late-onset neonatal hyperbilirubine-
mia. Follow-up visits should be recommended for 
all infants, especially for those who have the above 
risk factors.
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